BioLife Solutions Announces Second Quarter 2021 Financial Results

Go back to BioLife Solutions Announces Second Quarter 2021 Financial Results

BioLife Solutions (BLFS) PT Raised to $64 at Cowen

August 13, 2021 6:41 AM EDT

Cowen analyst Chris Lin raised the price target on BioLife Solutions (NASDAQ: BLFS) to $64.00 (from $50.00) while maintaining an Outperform rating.

The analyst commented, "BLFS delivered a healthy Q2 beat versus Street expectations, driven by strong organic growth (+49% Y/Y) and nearly +200 new... More

BioLife Solutions (BLFS) Tops Q2 EPS by 7c

August 12, 2021 4:21 PM EDT

BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of $0.00, $0.07 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $31.2 million versus the consensus estimate of $27.55 million.

GUIDANCE:

BioLife Solutions sees FY2021 revenue of $108-117 million, versus the consensus... More